{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:15:42Z","timestamp":1767863742779,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40256-025-00754-9","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T04:02:20Z","timestamp":1756699340000},"page":"7-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-0245","authenticated-orcid":false,"given":"Massimo","family":"Imazio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"754_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-025-00743-y","author":"HY Li","year":"2025","unstructured":"Li HY, Cheriyan J, Chan T-K, et al. Colchicine for the secondary prevention of cardiovascular diseases: a cumulative-dose meta-analysis of randomized controlled trials including 31 397 subjects worldwide. Am J Cardiovasc Drugs. 2025. https:\/\/doi.org\/10.1007\/s40256-025-00743-y.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"26","key":"754_CR2","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/eurheartj\/ehaf174","volume":"47","author":"M Samuel","year":"2025","unstructured":"Samuel M, Berry C, Dub\u00e9 MP, et al. Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis. Eur Heart J. 2025;47(26):2552\u201363. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf174.","journal-title":"Eur Heart J"},{"issue":"26","key":"754_CR3","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/eurheartj\/ehaf210","volume":"46","author":"MA d'Entremont","year":"2025","unstructured":"d\u2019Entremont MA, Poorthuis MHF, Fiolet ATL, et al. Colchicine for secondary prevention of vascular events: a meta-analysis of trials. Eur Heart J. 2025;46(26):2564\u201375. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf210.","journal-title":"Eur Heart J"},{"key":"754_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2025-325826","author":"R Huntermann","year":"2025","unstructured":"Huntermann R, Peres de Oliveira J, Barbosa LM, et al. Colchicine in acute coronary syndromes: a systematic review and meta-analysis of randomised controlled trials. Heart. 2025. https:\/\/doi.org\/10.1136\/heartjnl-2025-325826. (Epub ahead of print).","journal-title":"Heart"},{"key":"754_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf302","author":"B Tucker","year":"2025","unstructured":"Tucker B, Tucker WJ, Chung JS, Figtree GA, Keech A, Patel S. The efficacy and safety of low dose colchicine in atherosclerotic cardiovascular disease\u2014a systematic review and meta-analysis. Eur J Prev Cardiol. 2025. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf302. (Epub ahead of print).","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"754_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2459\/JCM.0000000000001744","volume":"26","author":"F Ballacci","year":"2025","unstructured":"Ballacci F, Giordano F, Conte C, Telesca A, Collini V, Imazio M. Colchicine for prevention of major adverse cardiovascular events: a meta-analysis of randomized clinical trials. J Cardiovasc Med (Hagerstown). 2025;26(7):359\u201368. https:\/\/doi.org\/10.2459\/JCM.0000000000001744.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"754_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf332","author":"A Abdelaziz","year":"2025","unstructured":"Abdelaziz A, Sobhy A, Nazmy A, et al. Colchicine for secondary prevention in established ASCVD: a systematic review and meta-analysis. Eur J Prev Cardiol. 2025. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf332. (Epub ahead of print).","journal-title":"Eur J Prev Cardiol"},{"issue":"10448","key":"754_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(24)00968-1","volume":"404","author":"P Kelly","year":"2024","unstructured":"Kelly P, Lemmens R, Weimar C, et al. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial. Lancet. 2024;404(10448):125\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(24)00968-1.","journal-title":"Lancet"},{"key":"754_CR9","doi-asserted-by":"publisher","unstructured":"Li J, Meng X, Shi FD, et al., CHANCE-3 Investigators. Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial. BMJ. 2024;385:e079061. https:\/\/doi.org\/10.1136\/bmj-2023-079061.","DOI":"10.1136\/bmj-2023-079061"},{"key":"754_CR10","doi-asserted-by":"publisher","unstructured":"Jolly SS, d\u2019Entremont MA, Lee SF, et al., CLEAR Investigators. Colchicine in acute myocardial infarction. N Engl J Med. 2025;392(7):633\u201342. https:\/\/doi.org\/10.1056\/NEJMoa2405922.","DOI":"10.1056\/NEJMoa2405922"},{"issue":"4","key":"754_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","volume":"61","author":"SM Nidorf","year":"2013","unstructured":"Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol. 2013;61(4):404\u201310. https:\/\/doi.org\/10.1016\/j.jacc.2012.10.027.","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"754_CR12","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2021372.","journal-title":"N Engl J Med"},{"issue":"26","key":"754_CR13","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497\u2013505. https:\/\/doi.org\/10.1056\/NEJMoa1912388.","journal-title":"N Engl J Med"},{"issue":"4","key":"754_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41569-025-01124-3","volume":"22","author":"M Imazio","year":"2025","unstructured":"Imazio M, Ballacci F, Giordano F. Colchicine in acute coronary syndromes: the present and the possible future. Nat Rev Cardiol. 2025;22(4):215\u20136. https:\/\/doi.org\/10.1038\/s41569-025-01124-3.","journal-title":"Nat Rev Cardiol"},{"key":"754_CR15","doi-asserted-by":"publisher","unstructured":"Vrints C, Andreotti F, Koskinas KC, et al., ESC Scientific Document Group. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537. https:\/\/doi.org\/10.1093\/eurheartj\/ehae177.","DOI":"10.1093\/eurheartj\/ehae177"},{"key":"754_CR16","doi-asserted-by":"publisher","unstructured":"Visseren FLJ, Mach F, Smulders YM, et al., ESC National Cardiac Societies, ESC Scientific Document Group. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227\u2013337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484.","DOI":"10.1093\/eurheartj\/ehab484"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-025-00754-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-025-00754-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-025-00754-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:02:27Z","timestamp":1767841347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-025-00754-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1007\/s40256-025-00754-9","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"14 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this commentary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dr. Imazio has no potential conflicts of interest that might be relevant to the contents of this commentary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Dr. Imazio was responsible for writing, reviewing, and editing this commentary.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"Data sharing is not applicable as no datasets were generated for this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}